Brii Biosciences Ltd Sustainability Reports

Brii Biosciences Limited is a biotechnology company developing therapies for significant infectious diseases and central nervous system disorders. The company focuses primarily on advancing functional cure treatments for the hepatitis B virus (HBV).

Sector: Manufacturing

Country: China

Exchange: Hong Kong Stock Exchange

FIGI: BBG011MPQG48

8 reports from 2021 to 2025

• Brii Biosciences Ltd 2025 Environmental, Social & Governance Report
• Brii Biosciences Ltd 2024 Environmental, Social and Governance Report
• Brii Biosciences Ltd 2024 Annual Report
• Brii Biosciences Ltd 2024 Environmental, Social & Governance Report
• Brii Biosciences Ltd 2023 Environmental, Social and Governance Report